IBMC
ibmc01 ibmc02 ibmc03 ibmc04 ibmc05 ibmc06 ibmc07 ibmc08 ibmc09 ibmc10 ibmc11 ibmc12
jQuery Image Slider by WOWSlider.com v2.0
web del Instituto de Biología Molecular y Celular

Director'sforeword


The Institute of Molecular and Cellular Biology (IBMC) is one of the University Research Institutes at the University Miguel Hernandez de Elche. The IBMC is located in the University Campus in Elche, occupying a 4,000 sq. m. of laboratory in the Torregaitán Building. The Institute was created in 2002 from a transformation of the Center of Molecular and Cellular Biology, thanks to the initiative and enthusiasm of its inspirator and first director Prof. José Manuel González-Ros, who had the vision of the importance of having a multidisciplinary research Institute in the University as a wise strategy to carry competitive and transferable research in the fields of Biomedicine and Biotechnology. This devotion to translational research has been a pivotal hallmark of the IBMC since its creation. As a result, in the past 15 years the IBMC has excelled in its scientific production as well as in the exploitation of the results generated by their groups. Furthermore, the interest of transferring the scientific results to society has thrust the creation of spin-off companies and Joint ventures with private enterprises and local Hospitals.

Inspection of the reported data indicate that research teams have been very active in securing funding from both governmental and private sources, publishing papers that are widely cited, training your scientist with the highest scientific standards as recognized by the Excellence Mention of our Doctorate program by the Ministry of Education, and to disseminate our activities and achievements to society. Notwithstanding, a major success of the Institute has been the commercialization of innovative products generated from the research projects in the fields of nutraceuticals, cosmeceuticals and biotechnology; and having a lead compound close to enter clinical development in humans. To reinforce the transferable activities, the Institute has created two technological platforms for strengthening our transferable activities.

This success has been possible thanks to our philosophy of potentiating collaborations and sharing all the infrastructures as a way to efficiently exploit the synergies and complementarities of our multidisciplinary group. All equipment is organized in functional units under the supervision of highly prepared technical staff, which allows a competent amortization by sharing its use. Similarly, our administrative personnel are greatly skilled on project financial management allowing that researchers focus on their scientific objectives.

Although we have walked a long and fruitful way, there is still plenty to do for increasing the IBMC international exposure and scientific distinction. In this regard, a Strategic Plan of Action has been approved by the Institute General Board that establishes the objectives and milestones for the next 5 years (2013-2017), strengthening the original vision, and establishing as a central mission to consolidate our multidisciplinary program of translational excellence in the areas of biotechnology and health, serving as a channel for taking the interest of basic research in these areas closer to the productive and service sectors of our society. Undoubtedly, it is our commitment to become a reference Institute in the arena of transferable knowledge.

Sincerely yours,

Prof. Antonio Ferrer-Montiel
IBMC Director